Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY1R | P25929 | 14/20 | 0.35 |
| ▸ | PARP1 | P09874 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23303909 | 1.00 | NPY1R (0.35) | NPY1RPARP1ALDH1A1CNR1CNR2 | |
| SCHEMBL23302562 | 1.00 | NPY1R (0.35) | NPY1RPARP1ALDH1A1CNR1CNR2 | |
| SCHEMBL24938894 | 0.91 | NPY1R (0.35) | NPY1RPARP1CNR1CNR2 | |
| SCHEMBL24939951 | 0.89 | CNR2 (0.35) | NPY1RPARP1CNR1CNR2 | |
| SCHEMBL24939890 | 0.88 | GSK3A (0.34) | NPY1RPARP1ALDH1A1 | |
| SCHEMBL24938970 | 0.88 | CYP1A2 (0.38) | NPY1RPARP1ALDH1A1 | |
| SCHEMBL24939893 | 0.87 | SMN1; SMN2 (0.36) | NPY1RPARP1 | |
| SCHEMBL24939989 | 0.86 | NPY1R (0.36) | NPY1R | |
| SCHEMBL24938953 | 0.85 | NPY1R (0.41) | NPY1R | |
| SCHEMBL24939986 | 0.85 | CYP2D6 (0.42) | NPY1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114630830-B | Novel compounds, pharmaceutical compositions comprising the same and uses thereof | 治愈医药社株式会社 | 2025-02-25 | — | — | CN | disclosed |
| CN-114630830-A | Novel compound and pharmaceutical composition for preventing or treating cancer comprising the same | 治愈医药社株式会社 | 2022-06-14 | — | — | CN | disclosed |